Sci Simple

New Science Research Articles Everyday

# Biology # Immunology

The Surprising Link Between Lungs, Cancer, and Viruses

Discover how lung infections impact cancer growth and treatment.

Ana Farias, Victoria Bridgeman, Felipe S. Rodrigues, Amber Owen, Stefanie Ruhland, Rute Ferreira, Matthias Mack, Ilaria Malanchi, Cecilia Johansson

― 8 min read


Lung Infections and Lung Infections and Cancer Growth the lungs. How viruses alter cancer dynamics in
Table of Contents

The lungs are remarkable organs that serve a very important purpose - they help us breathe. This makes them essential for our survival as they are in charge of getting oxygen into the body and removing carbon dioxide. But, as with many things in life, there’s more to the story, especially when the topic is cancer and viruses.

Lungs: The Gateway to Trouble

Located right at the interface between our bodies and the outside world, our lungs are constantly exposed to various elements. These can include tiny creatures (we call them microbes), allergens that make us sneeze, and pollutants that are less than friendly to our health. As a defense mechanism, the lungs have an advanced immune system that works like a bouncer at a nightclub. It keeps out troublemakers but sometimes lets in too many guests, causing chaos.

One downside to this protective system is that it creates an inviting space for cancer cells from other parts of the body to settle down and multiply. This phenomenon is called metastasis, and the lungs happen to be a popular destination for many Cancers, particularly colorectal and breast cancer. In fact, they are the second-most common site for cancer spread worldwide.

The Not-So-Happy Statistics

Cancer, in general, is a big health issue globally. It is the second leading cause of death after heart disease. Among women, invasive breast cancer is the most deadly type. That’s a lot of pressure on both our lungs and our bodies as a whole.

Viruses Invade the Scene

Now, let’s throw some viruses into the mix, shall we? Lower respiratory tract infections caused by viruses, such as influenza or respiratory syncytial virus (RSV), can lead to high rates of sickness and even death. These viruses love to take up residence in our lungs, often causing trouble that can become serious.

One can even get an RSV infection as a child, making it a frequent cause of bronchiolitis, a condition that inflames the smaller airways in the lungs. But guess who else is affected? The elderly and those with weak immune systems are also at a high risk of severe illness and death from such infections.

The Twisted Relationship Between Cancer and Viruses

It turns out that both lung cancer and respiratory infections can occur at the same time. Strange, right? While researchers have suggested that pneumonia and bronchiolitis might increase the risk of lung cancer, it’s not about just having cold symptoms. Most of the studies we have rely on self-reported instances, which is not entirely reliable.

What is needed is a deeper look into how infections like RSV can change the lung environment and influence the course of cancer. This is where things get interesting.

Our Defense Mechanism in Action

So how does the body fight back against viral invaders? Well, when respiratory viruses invade the lungs, they trigger a fast immune response. This response is supposed to limit the spread of the virus and help the body recover. It involves various Immune Cells getting together for a defense meeting, kind of like assembling a superhero team.

The immune system is smart enough to create a distinction between bad viruses and the body’s own cells. However, this response also changes the lung environment, potentially affecting how cancer cells grow or prevent them from spreading.

A Closer Look at Type I Interferons

One of the superheroes in our immune response is a group of proteins known as type I interferons (IFNs). These are crucial players in fighting off viral infections and can also take part in how cancer fights back. When the lungs are attacked by RSV, specific immune cells called alveolar macrophages produce type I IFNs to help in fighting off the virus.

Type I IFNs can stop the virus from copying itself and also help pull in other immune players to the site of infection. There’s a catch, though. While they are great at fighting off viruses, their role in cancer is more complicated. The question is whether the action of type I IFNs can also help in stopping metastasis in lung cancer.

The Experiment: Observing How RSV Affects Cancer Spread

Let’s talk about some experiments that were conducted to understand this relationship better. Researchers were curious if RSV could help reduce the spread of breast cancer cells in the lungs.

To test this out, they injected breast cancer cells into mice, first giving them an RSV infection. The goal was to see if the infection would reduce the number of cancer cells that were able to settle and grow in the lungs.

Surprisingly, the mice that had RSV infections ended up with fewer metastatic nodules in their lungs compared to those that didn’t have the infection. This seemed to indicate that RSV somehow created an environment in the lungs that was less welcoming to cancer cells.

So, What’s Happening in the Lungs?

So far, researchers have noted that the lungs become less conducive to the growth of cancer cells after a viral infection. By investigating how the lung environment is altered after an RSV infection, they hoped to understand the underlying mechanisms better.

During the RSV infection, a wave of immune cells rush in, and the body’s protective system goes into action. Changes in the lung tissue are significant, and various immune cells like neutrophils and monocytes are recruited to help the cause. However, when looking closely, researchers found out that removing just one type of immune cell from the equation didn’t revert everything to normal. Instead, it seems like multiple immune cell types might need to work together to create this anti-cancer environment.

The Role of Other Immune Cells

Neutrophils, monocytes, and NK (natural killer) cells were all looked at to see if they played a part in stopping the spread of cancer. However, researchers discovered that even when these immune cells were depleted, the RSV infection still caused a reduction in metastatic nodules. So, it wasn't just one type of cell making the difference.

This leads to the idea that the lung environment is so complex that it requires a collaborative effort from various immune cells to handle the situation and keep cancer in check.

The Power of Type I Interferons Revisited

Returning to type I interferons, researchers noticed that this group of proteins altered lung conditions quite a bit. When type I IFNs were administered directly to mice, similar results occurred as with RSV infection — fewer metastatic nodules were found. This observation implies that type I IFNs could mimic the positive effects of a viral infection in altering the lung environment.

In tests, when type I IFNs were given to mice that couldn’t respond to them, there was no reduction in metastatic nodules. This clearly indicates that the benefits of IFNs rely on their interactions with lung cells rather than directly affecting the cancer cells.

The Immune Response: A Dance of Cells

The immune system is akin to an intricate dance performance — when one dancer misses their cue, the whole show can falter. The study found that variations in the lung environment from type I IFN action were crucial for limiting metastatic spread.

Researchers were keen to see how the interactions between various lung cells changed in the presence of RSV and type I IFNs. They concluded that, during viral infections, interactions change between vascular (blood vessel) cells and cancer cells linked with cell growth and survival.

The Dynamic Nature of the Lung Environment

Many changes happen in the lung environment following exposure to RSV or type I IFNs. These changes can silence or enhance the growth signals that might otherwise benefit the cancer cells. The researchers also explored how specific lung epithelial cells, which play a role in supporting cancer growth, were less capable of nurturing the tumor cells after an RSV infection.

Interestingly, it was noted that lung fibroblasts, which are also crucial players, did not seem to have the same effect as the epithelial cells in terms of supporting cell growth.

Taking the Findings to the Next Level

Researchers hope their findings will help improve the understanding of how respiratory viruses and cancer interact, particularly as we’ve seen during events like the COVID-19 pandemic. The pandemic has drawn attention to how respiratory infections can impact those living with cancer.

Finally, it’s important to remember that while these findings may provide valuable insights into future therapies, humans are not mice. More research will be needed to see how these interactions translate in people.

Conclusion: The Lung’s Mixed Bag of Tricks

In the grand scheme, our lungs play an essential role not just in breathing but also in how diseases interact with each other. While they can be a hub for cancer spread, they can also create conditions that challenge the growth of tumors, especially when infections strike.

So, it turns out that even something as common as a viral infection can have significant implications for cancer growth. With the relationship between viruses and cancer being as complicated as a soap opera, it’s essential to keep peeling back the layers to see what’s really happening in those remarkable lungs of ours. Who knows? Maybe they have a few tricks left up their sleeves yet!

Original Source

Title: Type I interferons induced upon respiratory viral infection impair lung metastatic initiation

Abstract: Invasive breast cancer accounts for 7% of all cancer-related deaths, with the lungs being a common site of metastases. At the same time, lower respiratory tract infections are a common cause of morbidity and mortality worldwide. Acute viral respiratory infections induce transitional changes in the lung; however, the impact of these changes on metastasis initiation and cancer progression remains unclear. Using primary murine MMTV-PyMT breast cancer cells in an experimental lung metastasis model, we show that changes induced by respiratory syncytial virus (RSV) infection impair tumor cell seeding and early establishment in the lung, resulting in lower number of metastatic nodules. Furthermore, we demonstrate that this reduction of metastases is due to alterations in the lung environment mediated by type I interferons (IFNs) that are produced in response to RSV infection. Consistent with that notion, intranasal administration of recombinant IFN- recapitulates the anti-tumor effect of RSV infection. Type I IFNs change the lung cellular composition and induce an Interferon Stimulated Gene (ISG) driven response, creating an alveolar environment that is less supportive of tumor cell growth. Indeed, epithelial cells from mice infected with RSV or intranasally exposed to IFN-, are less supportive of tumor cell growth ex vivo. Altogether, our results suggest that type I IFNs induced by infection with some respiratory viruses perturb the lungs and consequently interfere with the ability of tumor cells to successfully initiate metastatic colonization. SignificanceWomen diagnosed with metastatic breast cancer have a low survival rate. The lungs are a common metastatic site and are constantly exposed to viral pathogens, such as coronavirus, RSV and influenza virus. Thus, breast cancer and respiratory virus infection are likely to co-occur, but their interplay remains unclear. We show that type I interferons (IFNs), induced upon viral infection impair metastatic cancer cell seeding of mouse lungs. This is potentially via an effect of IFNs on lung epithelial cells, which become less supportive of early tumor cell proliferation. These findings indicate that viral infections and type I IFNs can alter the lung environment and impair implantation of metastatic cells, which could be explored to improve future cancer treatments.

Authors: Ana Farias, Victoria Bridgeman, Felipe S. Rodrigues, Amber Owen, Stefanie Ruhland, Rute Ferreira, Matthias Mack, Ilaria Malanchi, Cecilia Johansson

Last Update: 2024-12-23 00:00:00

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.12.23.630113

Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.23.630113.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

Similar Articles